Abstract
2020 ASHP Midyear Clinical Meeting / New Orleans, Louisiana / Poster # RP-606
The objective of this medication use evaluation (MUE) was to assess the utilization and outcomes associated with dexmedetomidine in the treatment of alcohol withdrawal syndrome
Document Type
Article
Publication Date
2020
Recommended Citation
Kormanyos, Zsanett PharmD; Linn, Dustin D. PharmD, BCPS, BCCCP; and Coons, Jillian PharmD, BCPS, "Evaluation of dexmedetomidine use as an adjunctive therapy in the management of alcohol withdrawal syndrome" (2020). Parkview Pharmacy Department. 33.
https://researchrepository.parkviewhealth.org/pharma/33
